Lotus Pharmaceutical (Taiwan) Investor Sentiment

1795 Stock  TWD 271.50  4.00  1.45%   
Slightly above 61% of Lotus Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Lotus Pharmaceutical Co suggests that many traders are alarmed regarding Lotus Pharmaceutical's prospects. Lotus Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Lotus Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
Lotus Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lotus daily returns and investor perception about the current price of Lotus Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
NRx Pharmaceuticals, Inc. Announces Pricing of 2.0 Million Underwritten Public Offering of Common St...
Google News at Macroaxis
over six months ago at news.google.com         
Mukesh Ambani-owned companys shares surge 14 percent ahead of Q4 results - The Economic Times
Google News at Macroaxis
over six months ago at news.google.com         
Benign Growth For Lotus Pharmaceutical Co., Ltd. Underpins Its Share Price - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Lotus Pharmaceuticals Solid Profits Have Weak Fundamentals - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Is Lotus Pharmaceutical Co., Ltd.s Stocks Recent Performance Being Led By Its Attractive Financial ....
Google News at Macroaxis
over six months ago at news.google.com         
Is Lotus Pharmaceutical Co., Ltd.s Stocks Recent Performance Being Led By Its Attractive Financial P...
Google News at Macroaxis
over six months ago at news.google.com         
Share Dividend Announcement to Counter Short Selling at Upcoming Conference NRx Pharmaceuticals Nasd...
Google News at Macroaxis
over six months ago at news.google.com         
NRx Pharmaceuticals receives a 5 million milestone payment By Investing.com - Investing.com UK
Google News at Macroaxis
over six months ago at news.google.com         
NRx completes phase 2b3 trial enrollment for NRX-101 By Investing.com - Investing.com Australia
Google News at Macroaxis
over six months ago at news.google.com         
Innobic sells entire AMOLH stake - Bangkok Post
Google News at Macroaxis
over a year ago at news.google.com         
Alvotech Announces Positive Top-Line Results from a ... - StreetInsider.com
Google News at Macroaxis
over a year ago at news.google.com         
Barrons Stock Picks November 2023 - Barrons
Google News at Macroaxis
over a year ago at news.google.com         
Mumbai-bases DII buys stake in small-cap multibagger stock after 125 percent YTD rally - Mint
Google News at Macroaxis
over a year ago at news.google.com         
Alvotech and Bioventure Announce Approval of AVT02 in Egypt - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimers Dis...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Lotus Pharmaceutical that are available to investors today. That information is available publicly through Lotus media outlets and privately through word of mouth or via Lotus internal channels. However, regardless of the origin, that massive amount of Lotus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lotus Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lotus Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lotus Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lotus Pharmaceutical alpha.

Lotus Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Lotus Stock Analysis

When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.